Amexdrug Corporation (AXRX)

OTCMKTS · Delayed Price · Currency is USD

0.0002

+0.0001 (100.00%)

At close: Jul 30, 2025

-90.00% (1Y)

Market Cap	33.82K
Revenue (ttm)	9.17M
Net Income (ttm)	165.83K
Shares Out	169.11M
EPS (ttm)	0.00
PE Ratio	0.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	2,891
Open	0.0002
Previous Close	0.0001
Day's Range	0.0002 - 0.0002
52-Week Range	0.0001 - 0.0020
Beta	-0.54
RSI	32.66
Earnings Date	n/a

About Amexdrug

Amexdrug Corporation, through its subsidiaries, engages in the research, development, manufacturing, and distribution of pharmaceutical drugs in the United States. The company operates in two segments, Distribution, and Health and Beauty Products. It offers brand and generic pharmaceuticals, prescription and over-the-counter drugs, non-drug products, health and beauty products, nutritional supplements, as well as pharmacy and laboratory supplies under the Sponix brand name. The company is also involved in private manufacturing and labeling acti... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1963

Employees 11

Stock Exchange OTCMKTS

Ticker Symbol AXRX

Full Company Profile

Financial Performance

In 2012, Amexdrug's revenue was $9.15 million, a decrease of -26.26% compared to the previous year's $12.41 million. Earnings were $82,034, a decrease of -18.49%.

Financial Statements

News

There is no news available yet.